What Health Care Executives Should Know About EKRA
Please join Ryan S. Hedges and Anthony Pacheco, shareholders in Vedder Price’s Government Investigations & White Collar Defense group, for a webinar discussion of the Eliminating Kickbacks in Recovery Act (EKRA).
Since its passage in 2018, prosecutors have ramped up their reliance on EKRA’s new and extraordinary reach. The Act applies to services covered by both government and private health care programs, and prohibits remuneration provided in connection with referrals to and from laboratories, clinics, recovery centers, and other clinical treatment facilities. EKRA should be top of mind for health care executives as a developing area of the law and governmental priority, as it may require laboratories and certain health care entities to reassess their relationships with their contractors, employees and outside sales and marketing personnel, and will focus on private health care providers (not just on government health care programs).
During this webinar, participants will gain key insights regarding the following:
- The regulatory background and history of EKRA
- How the Act has been applied in practice, including discussion of notable recent investigations and prosecutions under the Act
- Key practical compliance considerations for all health care facilities and providers, public and private, including laboratories, clinics, recovery centers, and other clinical treatment facilities
Vedder Thinking | Events What Health Care Executives Should Know About EKRA
Webinar
When
May 6, 2021
1:00 PM - 1:30 PM Central Standard Time
Please join Ryan S. Hedges and Anthony Pacheco, shareholders in Vedder Price’s Government Investigations & White Collar Defense group, for a webinar discussion of the Eliminating Kickbacks in Recovery Act (EKRA).
Since its passage in 2018, prosecutors have ramped up their reliance on EKRA’s new and extraordinary reach. The Act applies to services covered by both government and private health care programs, and prohibits remuneration provided in connection with referrals to and from laboratories, clinics, recovery centers, and other clinical treatment facilities. EKRA should be top of mind for health care executives as a developing area of the law and governmental priority, as it may require laboratories and certain health care entities to reassess their relationships with their contractors, employees and outside sales and marketing personnel, and will focus on private health care providers (not just on government health care programs).
During this webinar, participants will gain key insights regarding the following:
- The regulatory background and history of EKRA
- How the Act has been applied in practice, including discussion of notable recent investigations and prosecutions under the Act
- Key practical compliance considerations for all health care facilities and providers, public and private, including laboratories, clinics, recovery centers, and other clinical treatment facilities